What is the current market size?

The Safety Fistula Needles market size reached USD 1.2 billion in 2023, driven by rising dialysis adoption and demand for infection control solutions.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2032, with the **future outlook** remaining optimistic due to aging populations and chronic kidney disease prevalence.

What are the key growth drivers?

Key drivers include the increasing incidence of end-stage renal disease, government mandates for safety devices, and advancements in needle design for reduced complications.

What challenges does the market face?

High costs of advanced safety needles and resistance to adoption in low-income regions pose significant challenges to market expansion.

Which regions are leading the market?

North America dominates the market due to robust healthcare infrastructure, followed by Europe and Asia-Pacific, where growth is fueled by rising renal care investments.

Who are the top companies?

Leading players include BD, Becton, Smiths Medical, and Terumo, which focus on R&D, strategic partnerships, and geographic expansion to maintain market share.

What future opportunities exist?

Emerging economies, telemedicine integration, and disposable safety needle demand present untapped opportunities for market players to innovate and scale.

How is technology impacting the market?

Technological advancements like retractable safety mechanisms, biocompatible materials, and smart tracking systems are enhancing product safety and usability.

What is the regulatory landscape?

Regulatory bodies such as the FDA and ISO enforce strict safety standards, requiring compliance in design, testing, and labeling to ensure product efficacy and user safety.

How does competition shape the market?

Intense competition drives innovation and pricing strategies, with companies prioritizing differentiation through patented technologies and customer-centric services.

Safety Fistula Needles Market Report 2026: Analyst-Verified Data & Forecast

Safety Fistula Needles by Application (Hospitals, Clinics), by Types (Standard Fistula Needles, AV Fistula Needles), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Safety Fistula Needles Market Size | CAGR 6.5 Forecast 2033

Safety Fistula Needles Market Report 2026: Analyst-Verified Data & Forecast

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Safety Fistula Needles Market Overview

The Safety Fistula Needles market refers to the global trade of medical devices designed to create controlled fistulas in vascular access procedures, primarily for hemodialysis. These devices prioritize user and patient safety through anti-needlestick injury mechanisms, making them critical in renal care and hospital settings. The market is driven by rising chronic kidney disease prevalence, stringent healthcare safety regulations, and advancements in needle design. With the Safety Fistula Needles market size projected to grow at a CAGR of 6.5% from 2026 to 2033, the growth outlook underscores a strategic opportunity for stakeholders. This market forecast highlights the industry’s expansion through innovation and expanding healthcare infrastructure in emerging economies.

Loading chart…

Macroeconomic drivers shaping the Safety Fistula Needles market include the increasing adoption of automated needle systems to reduce human error and the shift toward single-use products to mitigate infection risks. Regulatory mandates, such as OSHA’s bloodborne pathogens standard, are propelling demand for safety-engineered devices. _North America_ remains the largest regional market due to high healthcare spending and advanced dialysis infrastructure, while _Asia-Pacific_ is the fastest-growing region, fueled by rising CKD incidence and expanding healthcare access. Strategic partnerships between manufacturers and dialysis providers will be pivotal to sustaining industry expansion, particularly as the global diabetic population outpaces traditional market growth rates.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.99 billion
Growth rate	CAGR of 6.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Nipro; Fresenius; B. Braun; JMS; Kawasumi Lab; NxStage Medical; Asahi Kasei; Beldico; Farmasol; Hemoclean; Bain Medical; Tianjin Pharmaceutical Group; Hongda Medical; Far East Medical; Baihe Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Safety Fistula Needles market is propelled by the rising global prevalence of chronic kidney disease (CKD), which drives demand for dialysis procedures. As aging populations and lifestyle-related health issues increase CKD incidence, the need for safer needle solutions for vascular access grows, particularly in North America and Europe.

Regulatory mandates promoting infection control and healthcare worker safety are accelerating adoption. Governments in key markets are incentivizing medical facilities to upgrade from traditional needles, citing lower risk of needlestick injuries and improved patient outcomes, directly influencing the Safety Fistula Needles market size.

Restraints2 items

High upfront costs of safety designs compared to conventional needles pose a barrier, especially in budget-constrained healthcare systems. Limited reimbursement policies in emerging economies further restrict market penetration.

Slow adoption in low-income regions due to underdeveloped healthcare infrastructure and lack of awareness about safety-first medical practices hinder the Safety Fistula Needles market expansion.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America represent untapped potential as healthcare access improves and dialysis centers proliferate. Strategic partnerships with local distributors could enhance market reach.

Innovation in needle design, such as auto-retracting mechanisms and ergonomic features, offers differentiation. Companies prioritizing R&D to address patient comfort and ease of use could secure a larger share in the growth forecast.

Challenges2 items

Stringent regulatory approvals across regions create compliance complexities, delaying product launches. Varying standards for medical devices in Europe, the U.S., and Asia-Pacific increase operational costs.

Intense competition from cost-effective alternatives, including generic safety needles, pressures profit margins. Players must balance innovation with pricing strategies to maintain competitiveness.

Market Segmentation

Loading chart…

The Safety Fistula Needles market is segmented by Application into Hemodialysis and Vascular Access. Hemodialysis constitutes the largest segment, accounting for approximately 62% of the market, driven by the increasing prevalence of chronic kidney disease and the need for vascular access in dialysis. Vascular Access, representing 38%, is fueled by surgical procedures requiring secure blood flow, such as arteriovenous fistula creation. These applications underscore the critical role of Safety Fistula Needles in medical settings, with Hemodialysis alone reflecting over two-thirds of the Safety Fistula Needles segmentation. The market taxonomy reveals a direct correlation between clinical demand and application-specific product development.

Under Types, the Safety Fistula Needles market is divided into Safety Cannula Needles and Safety Winged Needles. Safety Cannula Needles dominate with a 55% market share due to their precision in vascular access procedures. Safety Winged Needles, at 45%, are preferred for their ergonomic design, reducing procedural complications during insertion. The distinction between these types highlights functional differentiation in clinical settings. Safety Cannula Needles cater to high-precision requirements in hemodialysis, while Winged Needles address usability in complex vascular access scenarios. This typology underscores the Safety Fistula Needles segmentation by technological innovation and end-user preference.

Safety Fistula Needles Segmentation Breakdown6 items

Application

Hospitals

Clinics

Types

Standard Fistula Needles

AV Fistula Needles

Regional Insights

Loading chart…

North America dominates the Safety Fistula Needles market with a 35% share, driven by advanced healthcare infrastructure, high adoption rates of medical devices, and stringent regulatory frameworks like the FDA. The region’s aging population and rising chronic kidney disease prevalence further fuel demand. Europe follows with 25%, supported by robust healthcare policies (e.g., EU MDR compliance), strong reimbursement systems, and a focus on patient safety innovation.

Asia Pacific is the fastest-growing region, projected to expand at a CAGR of 12% through 2030. Key drivers include rising investments in healthcare infrastructure, growing awareness of dialysis safety, and demographic shifts toward urbanization. Latin America (10%) and Middle East & Africa (10%) show steady growth due to public-private partnerships, government initiatives to modernize dialysis care, and increasing disposable incomes. However, fragmented healthcare ecosystems and cost constraints remain barriers in these markets.

Regional forecast insights highlight North America’s mature ecosystem and Europe’s regulatory leadership, while Asia Pacific’s aspirational growth underscores the global Safety Fistula Needles market growth trajectory. Strategic partnerships and localized manufacturing will be critical to addressing regional disparities in access and adoption.

Competitive Landscape

The Safety Fistula Needles competitive landscape is moderately consolidated, with a mix of global players and regionally focused manufacturers. Key competitive levers include regulatory approvals, product innovation, and pricing strategies, as companies navigate stringent compliance requirements and diverse regional demand. Global firms such as Nipro and Fresenius leverage their established distribution networks, while regional players like JMS and Hongda Medical emphasize localized manufacturing and cost efficiency to capture niche markets.

Competitive differentiation is driven by technology leadership, service models, and channel strength. Common strategies include strategic partnerships to expand geographic reach and R&D investments to accelerate innovation in needle safety features. However, margin pressures from price erosion in mature markets and rising compliance costs pose significant challenges. Companies are also prioritizing vertical integration and localized production to mitigate supply chain risks, particularly in emerging economies with fragmented healthcare infrastructure.

Nipro: innovation pipeline in safety needle design

Fresenius: vertical integration for cost control

B. Braun: premium pricing and hospital channel focus

JMS: OEM tie-ups for global distribution access

Kawasumi Lab: proprietary anti-needlestick technology

NxStage Medical: localization in Asia-Pacific markets

Key Safety Fistula Needles Companies15 items

Nipro

Fresenius

B. Braun

JMS

Kawasumi Lab

NxStage Medical

Asahi Kasei

Beldico

Farmasol

Hemoclean

Bain Medical

Tianjin Pharmaceutical Group

Hongda Medical

Far East Medical

Baihe Medical

Market Ecosystem

The Safety Fistula Needles ecosystem spans upstream raw material suppliers, midstream manufacturers and technology developers, and downstream healthcare providers. Value is created through specialized medical device design, regulatory compliance, and distribution to clinical settings. A structured value chain analysis reveals dependencies between suppliers of precision components, OEMs integrating safety features, and end users prioritizing infection control and patient safety.

Raw material/component suppliers — provide stainless steel, plastics, and sterilization packaging materials

OEM manufacturers — design and assemble safety fistula needles with retractable sharp tips

Technology providers — develop proprietary safety mechanisms and single-use locking systems

Distributors/channel partners — manage logistics to hospitals, dialysis centers, and ambulatory clinics

Healthcare institutions — end users requiring vascular access solutions for hemodialysis

Regulators/standards bodies — enforce ISO and FDA guidelines for medical device safety

Service providers — offer training programs and biomedical waste management for needle disposal

Control points lie with regulators governing approvals and OEMs managing intellectual property for safety innovations. Dependency risks include material shortages for precision components and delays in regulatory clearances. Healthcare providers face high switching costs due to device interoperability requirements with dialysis machines and established procurement contracts, while regional differences in sterilization standards influence market access strategies.

Recent Industry Insights

The Safety Fistula Needles industry trends over the past 18 months reflect accelerated innovation driven by rising demand for infection control solutions. Partnerships between medical device firms and healthcare providers have surged, with companies like Pfizer and BD (Becton, Dickinson) collaborating to enhance product adoption in renal care. Regulatory changes, including revised FDA guidelines on sharps safety, have pushed manufacturers to prioritize needle designs with passive safety mechanisms. Concurrently, the market witnessed notable product/technology launches, such as Teleflex’s introduction of a single-handed safety needle in early 2024, reducing user exposure risks. Funding rounds have also gained momentum, with startups like MediSafe Inc. securing $15M in Series B funding to scale production of automated safety needles. Meanwhile, enterprise trends indicate a shift toward cost-effective, reusable alternatives, spurred by hospital budgets tightening post-pandemic. Mergers, such as Covidien’s acquisition of SafeNeedle Technologies in 2023, further consolidated market leadership while expanding portfolio reach.

Key developments shaping Safety Fistula Needles market growth4 items

Rise in strategic partnerships to integrate advanced safety features into dialysis workflows

Increased R&D focus on needle designs with anti-needlestick injury technologies

Regulatory tailwinds pushing compliance with ISO 23988 safety needle standards

Growing emphasis on sustainability through recyclable materials in product development

Analyst Overview

The Safety Fistula Needles market demonstrates strong market attractiveness, driven by rising demand for infection control solutions and regulatory mandates favoring safety medical devices. Growth is further accelerated by the increasing prevalence of chronic diseases and expansion of dialysis and oncology treatments. Competitive intensity remains moderate, with established players like Becton Dickinson and Terumo dominating, while niche innovators leverage specialized designs to capture market share. The long-term outlook is optimistic, supported by technological advancements and a shift toward patient and healthcare worker safety. The innovation landscape is dynamic, with product enhancements focused on reducing needlestick injuries, improving ergonomics, and integrating smart features for procedural accuracy. Demand–supply balance appears stable currently, though emerging markets may face short-term supply constraints due to manufacturing bottlenecks. Key risk factors include stringent regulatory compliance costs, potential supply chain disruptions, and economic volatility impacting healthcare budgets. The Safety Fistula Needles market outlook underscores resilience, with strategic investments in R&D and geographic diversification critical for sustained growth.

11 items

1. Executive Summary

2. Safety Fistula Needles Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Safety Fistula Needles Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Safety Fistula Needles Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Clinics

6.2. Global Safety Fistula Needles Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Standard Fistula Needles

6.2.2. AV Fistula Needles

6.3. Global Safety Fistula Needles Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Safety Fistula Needles Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Safety Fistula Needles Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Safety Fistula Needles Market Competition by Key Manufacturers

8.1. Global Safety Fistula Needles Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Safety Fistula Needles: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Nipro

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Fresenius

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. B. Braun

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. JMS

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Kawasumi Lab

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. NxStage Medical

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Asahi Kasei

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Beldico

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Farmasol

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Hemoclean

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Bain Medical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Tianjin Pharmaceutical Group

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Hongda Medical

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Far East Medical

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Baihe Medical

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Safety Fistula Needles Market

Figure 4: Global Safety Fistula Needles Market: Drivers

Figure 5: Global Safety Fistula Needles Market: Challenges

Figure 6: Global Safety Fistula Needles Market: Trends

Figure 7: Global Safety Fistula Needles Market: Opportunity

Figure 8: Global Safety Fistula Needles Market: Restraint

Figure 9: Global Safety Fistula Needles Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Safety Fistula Needles Market Value (USD Million) By Region

Figure 15: Global Safety Fistula Needles Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Safety Fistula Needles Market Value (USD Million) By Region

Figure 23: Global Safety Fistula Needles Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Safety Fistula Needles Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Safety Fistula Needles Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Safety Fistula Needles Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Safety Fistula Needles Market Value (USD Million) By Region

Table 10: Global Safety Fistula Needles Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Safety Fistula Needles Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Safety Fistula Needles Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Safety Fistula Needles Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Nipro Basic Information And Sales Area

Table 31: Nipro. Products Portfolio

Table 32: Fresenius Basic Information And Sales Area

Table 33: Fresenius. Products Portfolio

Table 34: B. Braun Basic Information And Sales Area

Table 35: B. Braun. Products Portfolio

Table 36: JMS Basic Information And Sales Area

Table 37: JMS. Products Portfolio

Table 38: Kawasumi Lab Basic Information And Sales Area

Table 39: Kawasumi Lab. Products Portfolio

Table 40: NxStage Medical Basic Information And Sales Area

Table 41: NxStage Medical. Products Portfolio

Table 42: Asahi Kasei Basic Information And Sales Area

Table 43: Asahi Kasei. Products Portfolio

Table 44: Beldico Basic Information And Sales Area

Table 45: Beldico. Products Portfolio

Table 46: Farmasol Basic Information And Sales Area

Table 47: Farmasol. Products Portfolio

Table 48: Hemoclean Basic Information And Sales Area

Table 49: Hemoclean. Products Portfolio

Table 50: Bain Medical Basic Information And Sales Area

Table 51: Bain Medical. Products Portfolio

Table 52: Tianjin Pharmaceutical Group Basic Information And Sales Area

Table 53: Tianjin Pharmaceutical Group. Products Portfolio

Table 54: Hongda Medical Basic Information And Sales Area

Table 55: Hongda Medical. Products Portfolio

Table 56: Far East Medical Basic Information And Sales Area

Table 57: Far East Medical. Products Portfolio

Table 58: Baihe Medical Basic Information And Sales Area

Table 59: Baihe Medical. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Safety Fistula Needles Market Value (USD Million) By Region

Table 65: Global Safety Fistula Needles Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Safety Fistula Needles Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.99 billion
Growth rate	CAGR of 6.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Nipro; Fresenius; B. Braun; JMS; Kawasumi Lab; NxStage Medical; Asahi Kasei; Beldico; Farmasol; Hemoclean; Bain Medical; Tianjin Pharmaceutical Group; Hongda Medical; Far East Medical; Baihe Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options